Hechen Bioworkx
Latest round
- Series A
Last raised
- May 2026
Total raised
- $15M
Investors
- 6
About Hechen Bioworkx
Established in 2022 by co-founder Xie Xixian and based in Hefei, China, Hefei Hechen Biotechnology is a synthetic biology company focusing on the development and industrialization of functional active ingredients. is a synthetic biology company focusing on the development and industrialization of functional active ingredients. The core team members of the company are from Unilever, Coca-Cola and other companies as well as Tianjin University of Science and Technology and other institutions. Among them, the company's CTO, Dr. Weizheng Zhou, is an expert in the formulation and application of functional active ingredients and was the head of Unilever's Strategic Science Research Department in China. As of June 2026 Yu Hongjian is the CEO of the comapny. The company mainly focuses on strain technology development and industrialization application of synthetic organisms, and has now completed the construction of three platforms: SynBio Agile Development System, Highly Effective Active Ingredients Delivery and Agile BioFabrication. The core product built with the platform is L-Ergothioneine (EGT), an engineered bacterium that can effectively protect against UV damage and meet the needs of different application scenarios such as food, medicine and cosmetics. The company's revenue is generated through the development and industrialization of functional active ingredients.
Who invested in Hechen Bioworkx
6 investors across 3 rounds
See all investors in Hechen Bioworkx
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Hechen Bioworkx
Who invested in Hechen Bioworkx?
Hechen Bioworkx has 6 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Hechen Bioworkx raised?
Hechen Bioworkx has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Hechen Bioworkx last raise money?
Hechen Bioworkx's most recent round on record is a Series A, in May 2026.
What does Hechen Bioworkx do?
Established in 2022 by co-founder Xie Xixian and based in Hefei, China, Hefei Hechen Biotechnology is a synthetic biology company focusing on the development and industrialization of functional active ingredients.
Where is Hechen Bioworkx headquartered?
Hechen Bioworkx is headquartered in Hefei, China.
Which VCs invest in companies like Hechen Bioworkx?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at Hechen Bioworkx's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Hechen Bioworkx? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.